Hope and challenges for dendritic cell-based vaccine therapy for glioblastoma

World Neurosurgery

Volumn 77, Issue 5-6, 2012, Pages 633-635

  Nakano, Ichiro ^a   Chiocca, E Antonio ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Dendritic cells; Glioblastoma multiforme; Immunotherapy; Overall survival; Progression free survival; Vaccine

Indexed keywords

DENDRITIC CELL VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 3;

B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CANCER STEM CELL; CANCER SURVIVAL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GLIOBLASTOMA; HUMAN; IMMUNOTHERAPY; MEMORY T LYMPHOCYTE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; REVIEW; T LYMPHOCYTE;

EID: 84864132892     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2011.10.012     Document Type: Article

References (19)

1. D.D. Bigner, O.M. Pitts, C.J. Wikstrand Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue J Neurosurg 55 1981 32 42
2. L. Garcia-Hernandez Mde, A. Gray, B. Hubby, O.J. Klinger, W.M. Kast Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity Cancer Res 68 2008 861 869
3. C.S. Higano, P.F. Schellhammer, E.J. Small, P.A. Burch, J. Nemunaitis, L. Yuh, N. Provost, M.W. Frohlich Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer Cancer 115 2009 3670 3679
4. W. Kim, L.M. Liau Dendritic cell vaccines for brain tumors Neurosurg Clin N Am 21 2010 139 157
5. L.M. Liau, K.L. Black, N.A. Martin, S.N. Sykes, J.M. Bronstein, L. Jouben-Steele, P.S. Mischel, A. Belldegrun, T.F. Cloughesy Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides Case report Neurosurg Focus 9 2000 e8
6. G. Liu, K.L. Black, J.S. Yu Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination Exp Rev Vaccines 5 2006 233 247
7. P. Parajuli, S. Mathupala, A.E. Sloan Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells Neurosurgery 55 2004 1194 1204
8. S. Pellegatta, P.L. Poliani, D. Corno, F. Menghi, F. Ghielmetti, B. Suarez-Merino, V. Caldera, S. Nava, M. Ravanini, F. Facchetti, M.G. Bruzzone, G. Finocchiaro Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas Cancer Res 66 2006 10247 10252
9. H.S. Phillips, S. Kharbanda, R. Chen, W.F. Forrest, R.H. Soriano, T.D. Wu, A. Misra, J.M. Nigro, H. Colman, L. Soroceanu, P.M. Williams, Z. Modrusan, B.G. Feuerstein, K. Aldape Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 2006 157 173
10. R.M. Prins, S.K. Odesa, L.M. Liau Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model Cancer Res 63 2003 8487 8491
11. R.M. Prins, H. Soto, V. Konkankit, S.K. Odesa, A. Eskin, W.H. Yong, S.F. Nelson, L.M. Liau Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy Clin Cancer Res 17 2011 1603 1615
12. J.H. Sampson, G.E. Archer, D.A. Mitchell, A.B. Heimberger, J.E. Herndon 2nd, D. Lally-Goss, S. McGehee-Norman, A. Paolino, D.A. Reardon, A.H. Friedman, H.S. Friedman, D.D. Bigner An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme Mol Cancer Ther 8 2009 2773 2779
13. S. Van Gool, W. Maes, H. Ardon, T. Verschuere, S. Van Cauter, S. De Vleeschouwer Dendritic cell therapy of high-grade gliomas Brain Pathol 19 2009 694 712
14. R.G. Verhaak, K.A. Hoadley, E. Purdom, V. Wang, Y. Qi, M.D. Wilkerson, C.R. Miller, L. Ding, T. Golub, J.P. Mesirov, G. Alexe, M. Lawrence, M. O'Kelly, P. Tamayo, B.A. Weir, S. Gabriel, W. Winckler, S. Gupta, L. Jakkula, H.S. Feiler, J.G. Hodgson, C.D. James, J.N. Sarkaria, C. Brennan, A. Kahn, P.T. Spellman, R.K. Wilson, T.P. Speed, J.W. Gray, M. Meyerson, G. Getz, C.M. Perou, D.N. Hayes Cancer Genome Atlas Research Network: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell 17 2010 98 110
15. Q. Xu, G. Liu, X. Yuan, M. Xu, H. Wang, J. Ji, B. Konda, K.L. Black, J.S. Yu Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens Stem Cells 27 2009 1734 1740
16. R. Yamanaka, T. Abe, N. Yajima, N. Tsuchiya, J. Homma, T. Kobayashi, M. Narita, M. Takahashi, R. Tanaka Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial Br J Cancer 89 2003 1172 1179
17. R. Yamanaka, J. Homma, N. Yajima, N. Tsuchiya, M. Sano, T. Kobayashi, S. Yoshida, T. Abe, M. Narita, M. Takahashi, R. Tanaka Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial Clin Cancer Res 11 2005 4160 4167
18. J.S. Yu, G. Liu, H. Ying, W.H. Yong, K.L. Black, C.J. Wheeler Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Res 64 2004 4973 4979
19. J.S. Yu, C.J. Wheeler, P.M. Zeltzer, H. Ying, D.N. Finger, P.K. Lee, W.H. Yong, F. Incardona, R.C. Thompson, M.S. Riedinger, W. Zhang, R.M. Prins, K.L. Black Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration Cancer Res 61 2001 842 847